← Back to Search

Financial Incentives for Glaucoma Care Adherence

N/A

Recruiting

Led By Lindsay A Rhodes, MD, MSPH

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Anyone ≥ 18 years with a glaucoma associated diagnosis

Non-Hispanic white ≥50 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the time frame will be from baseline through 3 years of recruitment in the study.

Awards & highlights

Study Summary

This trial is testing a new way to detect and manage glaucoma, using telemedicine to improve access to care for a vulnerable population.

Who is the study for?

This trial is for adults over 18 with glaucoma-related diagnoses, diabetes, or a family history of glaucoma. It focuses on African Americans and Hispanics over 40, and non-Hispanic whites over 50. Participants must speak and understand English. There are no specific exclusion criteria.Check my eligibility

What is being tested?

The study is testing if giving people money can make them more likely to go to eye care appointments after being referred for conditions like cataract, glaucoma, diabetic retinopathy, etc., compared to not offering money.See study design

What are the potential side effects?

Since this trial involves financial incentives rather than medical treatments or drugs, there are no direct physical side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and have been diagnosed with glaucoma.

Select...

I am a non-Hispanic white person aged 50 or older.

Select...

I am 18 or older and have diabetes.

Select...

I can speak and understand English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the time frame will be from baseline through 3 years of recruitment in the study.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the time frame will be from baseline through 3 years of recruitment in the study.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the time frame will be from baseline through 3 years of recruitment in the study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of participants that adhere to referral appointment

Trial Design

2Treatment groups

Experimental Treatment

Group I: No financial incentiveExperimental Treatment1 Intervention

This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.

Group II: Financial incentiveExperimental Treatment1 Intervention

This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Financial Incentive

2016

N/A

~63450

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,476,402 Total Patients Enrolled

University of Alabama at BirminghamLead Sponsor

1,581 Previous Clinical Trials

2,277,029 Total Patients Enrolled

3 Trials studying Refractive Errors

440 Patients Enrolled for Refractive Errors

Lindsay A Rhodes, MD, MSPHPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Financial Incentive Clinical Trial Eligibility Overview. Trial Name: NCT04328207 — N/A

$Refractive Errors Research Study Groups: No financial incentive, Financial incentive$

$Refractive Errors Clinical Trial 2023: Financial Incentive Highlights & Side Effects. Trial Name: NCT04328207 — N/A$

Financial Incentive 2023 Treatment Timeline for Medical Study. Trial Name: NCT04328207 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment presently seeking participants?

"Indeed, the information hosted on clinicaltrials.gov verifies that this research is recruiting participants currently. It was initially posted in November 2020 and has been updated most recently as of March 2022. To complete the study, 1000 patients must be enrolled from one medical center."

Answered by AI

How many volunteers are participating in this experiment?

"Correct. According to clinicaltrials.gov, this medical study is actively recruiting participants who first saw the trial posted on November 18th 2020. This research requires 1000 patients to be recruited from a single site for completion."

Answered by AI